MARCH 2023LIFE SCIENCES REVIEW5CXO INSIGHTSLAST WORD20242628Craig Hopkinson, M.D., CMO and Head of Clinical Development and Medical Affairs, AlkermesKelly H. Zou, PhD, PStat®, FASA, Head of Global Medical Analytics and Real World Evidence, ViatrisNick Thomson, Executive Director Chemical Research and Development, PfizerPatrik Florencio, SVP and Chief Compliance & Risk Officer, Amicus Therapeutics andMichael Schneider, Vice President, Global Compliance Auditing and Monitoring and ERM, Amicus TherapeuticsSilji Abraham, Senior Vice President and Chief Technology Officer, West Pharmaceutical Services Optimizing Alkermes' R&D Model for SuccessArtificial Intelligence and the Healthcare IndustryThree C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientHow Technology Enhancesthe Effectiveness of Compliance ProgramsThree Ways Web 3.0 Will Revolutionize the Pharmaceutical BusinessIN MY OPINION08The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma IndustryPaul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations, Astellas Pharma US, Inc.30
< Page 4 | Page 6 >